Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas
NCT02223208Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Sep 2014
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
A Phase 2 trial of romidepsin in peripheral T-cell lymphoma (PTCL), sponsored by Fondazione Italiana Linfomi. Started Sep 2014; status: completed.
02
Drugs
romidepsin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT02223208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02223208.